Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

CLGN

CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLGN
FechaHoraFuenteTítuloSímboloCompañía
29/05/202406:28IH Market NewsUS Index Futures Drop Amid Rising Treasury Yields and Inflation Concerns, Oil Prices IncreaseNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/05/202406:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202406:31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202407:00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/01/202414:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLGNCollPlant Biotechnologies Ltd
22/09/202306:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
26/06/202306:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
14/06/202306:34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CLGNCollPlant Biotechnologies Ltd
18/04/202315:31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202307:26Business WireStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/03/202306:50Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CLGNCollPlant Biotechnologies Ltd
30/01/202313:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
13/01/202305:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLGNCollPlant Biotechnologies Ltd
06/01/202315:31Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/01/202306:00PR Newswire (US)CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of ObjectivesNASDAQ:CLGNCollPlant Biotechnologies Ltd
03/01/202306:00PR Newswire (US)CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder FormNASDAQ:CLGNCollPlant Biotechnologies Ltd
30/12/202215:32Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:CLGNCollPlant Biotechnologies Ltd
01/12/202206:00PR Newswire (US)CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial ResultsNASDAQ:CLGNCollPlant Biotechnologies Ltd
15/11/202206:00PR Newswire (US)CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative ColitisNASDAQ:CLGNCollPlant Biotechnologies Ltd
07/11/202206:00PR Newswire (US)CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90NASDAQ:CLGNCollPlant Biotechnologies Ltd
03/11/202206:00PR Newswire (US)CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17NASDAQ:CLGNCollPlant Biotechnologies Ltd
03/10/202206:00PR Newswire (US)CollPlant to present at the Dawson James Small Cap Growth Conference on October 12NASDAQ:CLGNCollPlant Biotechnologies Ltd
19/09/202206:00PR Newswire (US)CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, ItalyNASDAQ:CLGNCollPlant Biotechnologies Ltd
06/09/202206:00PR Newswire (US)CollPlant Biotechnologies to Participate in September Investor ConferencesNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/08/202206:00PR Newswire (US)CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial ResultsNASDAQ:CLGNCollPlant Biotechnologies Ltd
05/07/202206:00PR Newswire (US)CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, CanadaNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/06/202207:45PR Newswire (US)CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine StudyNASDAQ:CLGNCollPlant Biotechnologies Ltd
20/06/202204:01TipRanksAnalysts Are Bullish on These Healthcare Stocks: Collplant Holdings (CLGN)NASDAQ:CLGNCollPlant Biotechnologies Ltd
26/05/202206:00PR Newswire (US)CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial ResultsNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/04/202206:00PR Newswire (US)CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and ScreeningNASDAQ:CLGNCollPlant Biotechnologies Ltd
 Showing the most relevant articles for your search:NASDAQ:CLGN